期刊文献+

SIAH2在乳腺癌及癌旁组织中的差异表达及其临床意义 被引量:4

Clinical significance of differential expressions of SIAH2 in breast cacinoma and adjacent tissues
下载PDF
导出
摘要 目的观察人乳腺癌及癌旁组织中SIAH(seven in absentia homologues)2的表达情况,探讨SIAH2在乳腺癌及癌旁组织差异表达的临床意义。方法应用免疫组织化学检测110例乳腺癌及癌旁石蜡包埋组织中SIAH2,Western blotting和Realtime PCR检测35例乳腺癌及癌旁组织中SIAH2的蛋白表达情况。结果乳腺癌组织中SIAH2蛋白表达量明显高于癌旁乳腺组织中SIAH2蛋白表达量(P<0.05);乳腺癌组织中SIAH2mRNA表达量明显高于癌旁乳腺组织中SIAH2mRNA蛋白表达量(P<0.05)。结论 SIAH2过表达与乳腺癌密切关系。SIAH2可能成为防控乳腺癌的靶点。 Objective To explore the clinical significance of SIAH2(seven in absentia homologues) in breast carcinoma and adjacent tissues.Methods The SIAH2 expressions of all the 110 cases were detected by immunohistochemistry in whom 35 cases were randomly selected to evaluate the expression of SIAH2 by RT-PCR and Western blot methods.Results The expression of SIAH2 protein and mRNA in breast carcinoma was significantly higher than that of adjacent breast tissue(P<0.05).Conclusion There was a close relationship between higher SIAH2 expression and breast cancer.The SIAH2 may be a new target for breast carcinoma therapy.
出处 《岭南现代临床外科》 2012年第6期403-406,共4页 Lingnan Modern Clinics in Surgery
关键词 SIAH2 乳腺癌 癌旁组织 SIAH2 Breast carcinoma Adjacent tissues
  • 相关文献

参考文献1

共引文献6

同被引文献66

  • 1潘坤,戴爱国,胡瑞成.缺氧诱导因子家族蛋白的稳定性与转录活性的调节[J].医学分子生物学杂志,2006,3(1):44-47. 被引量:4
  • 2Tavassoli FA.乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹等译.北京:人民卫生出版社,2006.312.
  • 3Wang Y, Colicelli J. RAS interaction with effector target RIN1. Methods Enzymol,2001;332:139-151.
  • 4Shan GY, Zhang Z, Chen QG, Yu XY, Liu GB, Kong CZ. Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma. Tumour Biol,2012;33:847-855.
  • 5Schmidt RL, Park CH, Ahmed AU, Gundelach JH, Reed NR, Cheng S, Knudsen BE, Tang AH. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res,200767:11798-11810.
  • 6Tomshine JC, Severson SR, Wigle DA, Sun Z, Beleford DA, Shridhar V, Horazdovsky BF. Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem,2009;284:26331-26339.
  • 7Yu HF, Zhao G, Ge ZJ, Wang DR, Chen J, Zhang Y, Zha TZ, Zhang K, Zhang M, Tan YF, Zhou SJ, Jiang C. High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol,2012;33:1557-1563.
  • 8Xu L, Lubkov V, Taylor LJ, Bar-Sagi D. Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination. Curr Biol,2010;20:1372-1377.
  • 9Balaji K, Mooser C, Janson CM, Bliss JM, Hojjat H, Colicelli J. RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR. J Cell Sci,2012;125:5887-5896.
  • 10Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J. ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1. Leukemia,2011;25:290-300.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部